Ian Burns

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Comparison of a commercial modified factor VIII bethesda inhibitor assay to current factor VIII inhibitor assay methods in a multicenter trial.

Comparison of a commercial modified factor VIII bethesda inhibitor assay to current factor VIII inhibitor assay methods in a multicenter trial.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: January 26, 2026

Tumor-derived cell-free DNA detected in cerebrospinal fluid enables minimally invasive profiling of pediatric brain tumors.

Tumor-derived cell-free DNA detected in cerebrospinal fluid enables minimally invasive profiling of pediatric brain tumors.

Journal: The Journal of clinical investigation

Published: July 07, 2025

Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma.

Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma.

Journal: Neuro-oncology

Published: June 11, 2025

High detection rate of circulating-tumor DNA from cerebrospinal fluid of children with central nervous system germ cell tumors.

High detection rate of circulating-tumor DNA from cerebrospinal fluid of children with central nervous system germ cell tumors.

Journal: Acta neuropathologica communications

Published: September 16, 2024

Fate Specification of GFAP-Negative Primitive Neural Stem Cells and Their Progeny at Clonal Resolution.

Fate Specification of GFAP-Negative Primitive Neural Stem Cells and Their Progeny at Clonal Resolution.

Journal: Stem cells and development

Published: August 08, 2023

Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.

Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.

Journal: Nature communications

Published: January 10, 2023

Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma.

Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma.

Journal: Cancer cell

Published: June 26, 2022

Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review.

Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review.

Journal: European journal of haematology

Published: March 23, 2022

Childhood Medulloblastoma: An Overview.

Childhood Medulloblastoma: An Overview.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 03, 2022

Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.

Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.

Journal: Science advances

Published: December 08, 2021

The Road to CAR T-Cell Therapies for Pediatric CNS Tumors: Obstacles and New Avenues.

The Road to CAR T-Cell Therapies for Pediatric CNS Tumors: Obstacles and New Avenues.

Journal: Frontiers in oncology

Published: November 15, 2021

Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.

Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.

Journal: Nature communications

Published: May 21, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026